Marshall Wace »

Y Mabs Therapeutics shares owned by Marshall Wace

Quarter-by-quarter ownership of Y Mabs Therapeutics (YMAB) shares owned by Marshall Wace from 13F filings

Historical chart of Marshall Wace investment in Y Mabs Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Y Mabs Therapeutics held by Marshall Wace consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Y Mabs Therapeutics by Marshall Wace

Quarter filed Position value Share count Share price at filing
2023-12-31 $783k 115k 6.82
2023-09-30 $539k 99k 5.45
2023-06-30 $867k 128k 6.79
2022-09-30 $295k 21k 14.41
2021-06-30 $415k 12k 33.75
2019-09-30 $29k 1.1k 26.36

More positions owned by Marshall Wace

Ishares-s&p 500 Etp (IVV)
Amazon.com Common Stock (AMZN)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Spdr S&p 500 Etf Equity Option Call Option (SPY)
Alphabet Inc-a Equity Option Put Option (GOOGL)
Meta Platforms-a Common Stock (META)
Alphabet Inc-c Common Stock (GOOG)
Walmart Common Stock (WMT)
Abbvie Equity Option Put Option (ABBV)
Las Vegas Sands Common Stock (LVS)
Dr Horton Common Stock (DHI)
Ishares-leh 20 Equity Option Call Option (TLT)
Eli Lilly & Co Right Call Option
General Electric Common Stock (GE)

View all positions for Marshall Wace

Top funds holding Y Mabs Therapeutics

Vanguard Group
D. E. Shaw & Co
Caligan Partners
Goldman Sachs Group
Dimensional Fund Advisors
Jacobs Levy Equity Management
Charles Schwab Investment Management
Connor, Clark & Lunn Investment Management
Two Sigma Advisers
Soleus Capital Management
Citadel Advisors
Thomas Stevens, CFA"
Marshall Wace
Bank of New York Mellon
Rice Hall James & Associates

View all funds holding Y Mabs Therapeutics